Ledger.Open graph →
SEC Form D · filed May 20, 2015

Kinex Pharmaceuticals, Inc

Offering
$62.8M
Sold
$48.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BUFFALO, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Johnson Lau · BUFFALO, NYExec · DirectorJinn Wu · BUFFALO, NYDirectorFlint Besecker · BUFFALO, NYExec · DirectorPiney Point Capital GP LLC · Milwaukee, WIExec · DirectorCharles Lannon · BUFFALO, NYDirectorMichael Murphy · Vancouver, British Columbia, CanadaDirectorNicola (Nick) Sanna · Spokane, WAExec · DirectorJinn Wu · BUFFALO, NYDirectorCharles Lannon · BUFFALO, NYDirectorMichael Murphy · New York, NYDirectorFlint Besecker · BUFFALO, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗